Showing results (1-10 of 288) with videos related to
Sort By:
Pageof 29
Handbook of Clinical Neurology|March 17, 2024
Hematologic malignancies and hematopoietic stem cell transplantationChiara Briani, Andrea VisentinNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 29, 2022
Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating NeuropathiesChiara Briani, Andrea VisentinHandbook of Clinical Neurology|January 12, 2026
Immunotherapies in chronic immune-mediated neuropathiesChiara Briani, Andrea VisentinExpert Opinion on Investigational Drugs|December 28, 2023
Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders?Andrea Visentin, Marco Puthenparampil, Chiara BrianiJournal of the Peripheral Nervous System : JPNS|July 21, 2020
From pathogenesis to personalized treatments of neuropathies in hematological malignanciesChiara Briani, Andrea Visentin, Federica Cerri, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 10, 2024
Neuropathy with anti-myelin-associated glycoprotein antibodies: update on diagnosis, pathophysiology and managementYoung Gi Min, Andrea Visentin, Chiara Briani, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2022
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG AntibodiesChiara Briani, Andrea Visentin, Francesca Castellani, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2022
The BCL2 Inhibitor Venetoclax Plus Rituximab Is Active in MYD88 Wild-Type Polyneuropathy With Anti-MAG AntibodiesChiara Briani, Andrea Visentin, Francesca Castellani, et al.Cancers|December 23, 2022
Neurological Complications of Conventional and Novel Anticancer TreatmentsPaola Alberti, Alessandro Salvalaggio, Andreas A Argyriou, et al.European Journal of Neurology|February 24, 2026
Chronic Ataxic Neuropathy With Disialosyl Antibodies Responsive to ZanubrutinibBenedetta Tierro, Andrea Visentin, Alessandro Salvalaggio, et al.Pageof 29